Masahiro Ohtoshi
About
In The Last Decade
Masahiro Ohtoshi
15 papers receiving 353 citations
Peers
Comparison fields: 5 of 38
- Pulmonary and Respiratory Medicine 268
- Gastroenterology 182
- Surgery 153
- Oncology 48
- Hepatology 39
Countries citing papers authored by Masahiro Ohtoshi
This map shows the geographic impact of Masahiro Ohtoshi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masahiro Ohtoshi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masahiro Ohtoshi more than expected).
Fields of papers citing papers by Masahiro Ohtoshi
This network shows the impact of papers produced by Masahiro Ohtoshi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masahiro Ohtoshi. The network helps show where Masahiro Ohtoshi may publish in the future.
Co-authorship network of co-authors of Masahiro Ohtoshi
This figure shows the co-authorship network connecting the top 25 collaborators of Masahiro Ohtoshi. A scholar is included among the top collaborators of Masahiro Ohtoshi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masahiro Ohtoshi. Masahiro Ohtoshi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 9 | |
| 3 | [Analysis of microsatellite instability and p53 LOH in advanced colorectal cancers--first report of the No. 3 protocol]. | 1 |
| 4 | 247 | |
| 5 | [Three cases of advanced gastric cancer treated by TS-1 in combination with low-dose cisplatinum]. | 1 |
| 6 | 1 | |
| 7 | 1 | |
| 8 | 5 | |
| 9 | 11 | |
| 10 | [Correlation between pyrimidine nucleoside phosphorylase (PyNPase)/thymidine phosphorylase/platelet-derived endothelial cell growth factor and histological prognostic factor, and influence of 5'-deoxy-5-fluorouridine (5'-DFUR) administration on PyNPase activities and serum immunosuppressive acidic protein levels. A study group of oral anti-cancer drugs in Seiban/Tajima area]. | 1 |
| 11 | 4 | |
| 12 | 19 | |
| 13 | 22 | |
| 14 | 26 | |
| 15 | 12 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.